Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Return on Assets (%) | 8.129 | 11.167 | 11.561 | 10.089 | 6.386 | 11.016 | 13.002 | 9.172 |
Return on Equity (%) | 26.501 | 33.918 | 30.402 | 24.25 | 14.829 | 24.545 | 28.313 | 19.968 |
Return on Invested Capital (%) | 13.754 | 16.063 | 19.158 | 17.974 | 12.922 | 19.564 | 20.735 | 14.724 |
Operating Margin (%) | 13.502 | 14.449 | 15.221 | 15.017 | 10.907 | 16.215 | 16.929 | 13.68 |
Net Profit Margin (%) | 7.78 | 10.374 | 10.521 | 10 | 7.035 | 10.881 | 12.147 | 9.807 |
Book Value Per Share | 6.903 | 9.397 | 14.552 | 19.135 | 21.963 | 25.369 | 27.579 | 31.726 |
Earnings Per Share | 4.773 | 7.09 | 7.81 | 7.354 | 4.941 | 8.996 | 11.48 | 8.538 |
Cash Per Share | 2.54 | 2.3 | 3.825 | 7.175 | 10.281 | 6.617 | 3.567 | 7.23 |
Working Capital Per Share | 11.368 | 11.478 | 15.042 | 18.528 | 20.756 | 19.764 | 18.203 | 22.189 |
Operating Profit Per Share | 17.452 | 20.036 | 21.819 | 21.608 | 18.897 | 24.698 | 28.373 | 24.702 |
EBIT Per Share | 7.309 | 8.787 | 10.27 | 9.683 | 6.752 | 11.858 | 15.215 | 11.315 |
EBITDA Per Share | 7.309 | 8.787 | 10.27 | 9.683 | 6.752 | 11.858 | 15.215 | 11.315 |
Free Cash Flow Per Share | 6.298 | 9.162 | 12.441 | 10.698 | 8.481 | 15.089 | 20.522 | 13.067 |
Fin d'année 31 Décembre 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
Current Ratio | 2.712 | 2.3 | 3.049 | 3.424 | 3.514 | 3.088 | 2.865 | 2.571 |
Quick Ratio | 1.485 | 1.258 | 1.822 | 2.229 | 2.444 | 2.007 | 1.641 | 1.718 |
Inventory Turnover (Days) | 45.702 | 43.183 | 41.399 | 41.619 | 43.192 | 42.613 | 42.075 | 47.393 |
Actions en circulation | 94,2M | 94,3M | 94,5M | 94,7M | 94,8M | 93,5M | 89,7M | N/A |
Fin d'année 31 Décembre 2023 | Mar 2022 | Juin 2022 | Sept 2022 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 |
---|---|---|---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Actions en circulation | 93,7M | 93,7M | 92,7M | 89,7M | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | 16.855 | N/A | N/A | N/A | 13.596 | N/A | N/A | N/A |
Net Profit Margin (%) | 11.899 | N/A | N/A | N/A | 9.619 | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | 2.965 | N/A | N/A | N/A | 3.119 | N/A | N/A | N/A |
Quick Ratio | 1.912 | N/A | N/A | N/A | 1.803 | N/A | N/A | N/A |
Inventory Turnover (Days) | 160.802 | N/A | N/A | N/A | 185.317 | N/A | N/A | N/A |
Capitalisation boursière | 16,08B |
Ratio cours/bénéfice | 21,01 |
Ratio prix/ventes | 2,06 |
Ratio prix/liquidités | 24,81 |
Ratio prix/valeur comptable | 4,02 |
Rendement de dividende | 277,50% |
Actions en circulation | 89,62M |
Volume moyen (1 semaine) | 463,73k |
Volume moyen (1 mois) | 713,85k |
Variation sur 52 semaines | 36,15% |
Plus haut sur 52 semaines | 191,27 |
Plus bas sur 52 semaines | 122,20 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales